BamSEC and AlphaSense Join Forces
Learn More

Raphael Pharmaceutical Inc Com

OTC: RAPH    
Share price (11/6/24): $0.26    
Market cap (11/6/24): $4.862 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 10-K 1 page Extension of Appointment as a Member of the Board of Directors
12/34/56
EX-10.1
from 8-K/A 5 pages This Service Agreement (This “Agreement”) Is Made as of 5th of July, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”),, and Dr. Igal Louria Hayon (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal
12/34/56
EX-10.1
from 10-Q 7 pages Appendix to the Agreement Date July 07, 2019 Signed at October 23, 2022
12/34/56
EX-10.5
from 8-K 3 pages This Service Agreement (This “Agreement”) Is Made as of July 5th, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Eliya Yehuda I.D 025721069, (The “Director”/So Called “Yehuda”). Recitals 1. Appointment of Director; Relationship of Company and Yehuda
12/34/56
EX-10.4
from 8-K 5 pages This Service Agreement (This “Agreement”) Is Made as of 5th of July, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”),, and Dr. Igal Louria Hayon (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal
12/34/56
EX-10.3
from 8-K 5 pages This Operations Agreement (This “Agreement”) Is Made as of July 5th ,2022, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Guy Ofir & Co. Srl a Romanian Company No. J40/1123/2007 or Adv’ Guy Ofir I.D. 172910400069 (The “CFO, Legal Adviser & Director”). Recitals 1. Appointment of CFO, Legal Adviser & Director and It’s Relationship With the Company
12/34/56
EX-10.2
from 8-K 5 pages This Management and Operations Agreement (This “Agreement”) Is Made as of July 5th 2022, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Sheffa Enterprises, Inc., a New Jersey Corporation/ Shlomo Pilo (The “Manager”). Recitals 1. Appointment of Manager; Relationship of Company and the Manager
12/34/56
EX-10.1
from 8-K 3 pages This Service Agreement (This “Agreement”) Is Made as of 30th of June, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Joseph Press (The “Adviser”/So Called “Joseph”). Recitals 1. Appointment of Joseph to Be Medical Adviser; Relationship of Company and Joseph
12/34/56
EX-10.6
from 10-12G/A 27 pages Sponsored Research Agreement With Rambam Med-Tech Ltd
12/34/56
EX-10.5
from 10-12G/A 18 pages Contractual Agreement Between Raphael Pharmaceutical Ltd. and Way of Life Cannabis Ltd
12/34/56
EX-10.4
from 10-12G/A 2 pages Services Agreement for Finance Services Between Raphael Pharmaceutical Ltd. and Shimony Yosef Certified Public Accountant (Isr.)
12/34/56
EX-10.3
from 10-12G/A 6 pages Consulting Agreement With Sheffa Enterprises, Inc
12/34/56
EX-10.2
from 10-12G/A 9 pages Form of Indemnification Agreement
12/34/56
EX-10.1
from 10-12G/A 47 pages Share Exchange Agreement by and Between Easy Energy, Inc. and Raphael Pharmaceutical Ltd
12/34/56
EX-10.6
from 10-12G 13 pages Sponsored Research Agreement With Rambam Med-Tech Ltd.
12/34/56
EX-10.5
from 10-12G 18 pages Contractual Agreement Between Raphael Pharmaceutical Ltd. and Way of Life Cannabis Ltd
12/34/56
EX-10.4
from 10-12G 2 pages Services Agreement for Finance Services Between Raphael Pharmaceutical Ltd. and Shimony Yosef Certified Public Accountant (Isr.)
12/34/56
EX-10.3
from 10-12G 6 pages Consulting Agreement With Sheffa Enterprises, Inc
12/34/56
EX-10.2
from 10-12G 9 pages Form of Indemnification Agreement
12/34/56
EX-10.1
from 10-12G 61 pages Share Exchange Agreement by and Between Easy Energy, Inc. and Raphael Pharmaceutical Ltd
12/34/56